HB
H&R BLOCK INC (HRB)·Q4 2025 Earnings Summary
Executive Summary
- Q4 2025 delivered solid top-line performance but mixed bottom-line outcomes: revenue rose 4.6% year over year to $1.111B, while adjusted EPS was $2.27; management reiterated strong cash generation and raised the dividend 12% to $0.42 per share .
- Results vs consensus: revenue beat Wall Street ($1.111B vs $1.075B), but EPS missed ($2.27 vs $2.83) primarily due to a delayed one-time tax benefit expected in Q4, pushing the effective tax rate higher in FY25 and deferring ~$0.50 EPS tailwind beyond FY25 (Values retrieved from S&P Global)* .
- FY2026 outlook introduced: revenue $3.875–$3.895B, EBITDA $1.015–$1.035B, ETR ~25%, adjusted EPS $4.85–$5.00; share repurchases of ~$400M contemplated in H1 FY26 subject to conditions .
- Strategic traction continued: Assisted conversion improved again, DIY AI Tax Assist conversion uplift sustained, small-business/Wave growth strong; catalysts include dividend hike, revenue beat, and multi-year transformation progress .
What Went Well and What Went Wrong
What Went Well
- Assisted and DIY both grew in FY25: “assisted revenue grew by 6.1% and DIY revenue grew by 9.7%,” supported by higher complexity mix and improved conversion for a second consecutive year .
- Small business delivered a “record revenue year” with double-digit growth and Wave revenue up 13% for FY25; Wave’s paid products (e.g., ProTier) helped drive monetization .
- Capital returns and dividend: $600M returned via dividends and buybacks in FY25; quarterly dividend increased 12% to $0.42, marking eight consecutive annual increases .
What Went Wrong
- EPS miss vs consensus due to delayed one-time tax benefit in Q4 FY25; effective tax rate landed ~22% for FY25 vs prior guidance of ~13% that had contemplated ~$0.50 EPS tailwind (Values retrieved from S&P Global for consensus)* .
- Elevated costs: healthcare, legal (fees/settlements), and severance pressured FY25 EBITDA vs original expectations; FY26 guidance incorporates higher exit rates for healthcare and legal .
- Emerald Advance interest/fee income declined year over year on lower originations and tighter underwriting to improve credit outcomes .
Financial Results
Quarterly Performance vs Prior Periods and Estimates
Note: Asterisks denote values retrieved from S&P Global. Values retrieved from S&P Global.*
Actual vs Wall Street Consensus (Q4 2025)
Note: Asterisks denote values retrieved from S&P Global. Values retrieved from S&P Global.*
Segment Breakdown (Q4 2025 vs Q4 2024)
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “We are pleased to report total revenue growth of 4.2%… delivered $976 million of EBITDA… announced a 12% increase to our quarterly dividend” .
- CFO: “Total operating expenses… increased 4.6%… elevated healthcare costs and legal fees and settlements were meaningful contributors… we incurred severance charges in Q4” .
- CFO on FY26: “Revenue $3,875–$3,895B; EBITDA $1,015–$1,035B; ETR ~25%; adjusted EPS $4.85–$5.00… assumes ~$400M of repurchases in H1 FY26” .
- CEO succession: Jeff Jones to retire 12/31/2025; Curtis appointed CEO effective 1/1/2026; continuity of strategy emphasized .
Q&A Highlights
- Assisted vs DIY outlook: Management assumes a similar assisted mix shift as seen in the 2025 tax season; aim to halve share losses at FY26 midpoint via better qualified traffic and conversion .
- Margin bridge and costs: FY26 guidance includes higher healthcare/legal exit rates; cost savings from FY25 realignment plus ongoing belt-tightening and cost-out opportunities expected to improve flow-through .
- Bank products: Potential for higher refunds; specifics of early-season tactics held for competitive reasons; Emerald Advance underwriting balanced approval vs repayment, no plan to discontinue .
- Competitive landscape & direct file: Independents remain primary assisted competitors; direct file impact remains limited to free users; continued emphasis on transparent pricing and avoiding upsell pain points .
Estimates Context
- For Q4 2025, HRB beat revenue consensus but missed EPS: $1.111B actual vs $1.075B consensus; $2.27 EPS actual vs $2.83 consensus (Values retrieved from S&P Global)*. The EPS miss was driven by the delay of an anticipated one-time tax benefit in Q4, lifting the FY25 effective tax rate to ~22% rather than ~13% previously guided .
- Implications: Near-term EPS expectations may be revised lower to reflect timing of tax benefit recognition; FY26 EPS guide ($4.85–$5.00) positions for growth via cost actions, mix improvements, and buybacks .
Key Takeaways for Investors
- Revenue resilience with improving mix and conversion supports the topline; dividend raised and buyback capacity intact—a supportive capital return backdrop .
- Near-term EPS pressure from delayed tax benefit timing, but structural cost actions and FY26 guide suggest improving flow-through; monitor FY26 margin execution .
- Small-business and Wave growth are durable levers; continued traction can diversify beyond seasonal consumer tax cycles .
- Assisted channel momentum persists with enhanced client experience; strategy focuses on higher-value, complex filers and conversion—key to sustained share stabilization .
- Financial products: Spruce engagement is healthy; Emerald Advance remains a managed risk-return product—expect conservative underwriting and lower fee income until bad debt trends normalize .
- Leadership transition planned and internal; strategy continuity reduces execution risk—focus on November Q1 call for tax season specifics .
- Trading setup: Topline beat and dividend hike are positives; EPS miss from tax timing is transitory; watch estimate revisions and FY26 cost-out delivery for medium-term multiple support .
Notes: Asterisks in tables indicate values retrieved from S&P Global. Values retrieved from S&P Global.